Results of a randomized double‐blind study evaluating luvadaxistat in adults with Friedreich ataxia
Sign Up to like & getrecommendations! Published in 2021 at "Annals of Clinical and Translational Neurology"
DOI: 10.1002/acn3.51373
Abstract: Friedreich ataxia (FRDA) is a rare disorder with progressive neurodegeneration and cardiomyopathy. Luvadaxistat (also known as TAK‐831; NBI‐1065844), an inhibitor of the enzyme d‐amino acid oxidase, has demonstrated beneficial effects in preclinical models relevant to… read more here.
Keywords: randomized double; luvadaxistat adults; friedreich ataxia; study ... See more keywords